Compare $HCWB vs $VCNX | Chartloom

Compare

$HCWB vs $VCNX

HCW Biologics Inc · Vaccinex Inc

HCWB

HCW Biologics Inc

VCNX

Vaccinex Inc

Compare $HCWB vs $VCNX

Comparing HCW Biologics Inc and Vaccinex Inc

HCWBHCW Biologics Inc

VCNXVaccinex Inc

HCWBHCW Biologics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

707.0%

YTD performance

-76.2%

52W performance

-94.5%

FCF yield

-474.1%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HCWB

VCNX

Detailed metrics comparison

HCWB

HCW Biologics Inc

VCNX

Vaccinex Inc

Market Cap

HCWB$3M

VCNX$3M

Enterprise Value

HCWB$8M

VCNX$2M

Price

HCWB$1.60

VCNX$1.14

P/E Ratio

HCWBN/A

VCNXN/A

P/S Ratio

HCWB0.38x

VCNX5.08x

EV/Sales

HCWB1.25x

VCNX3.28x

EV/EBITDA

HCWB0.00x

VCNX0.00x

P/B Ratio

HCWB0.51x

VCNX1.15x

P/FCF Ratio

HCWBN/A

VCNXN/A

EV/FCF

HCWB-0.69x

VCNX-0.12x

PEG Ratio

HCWBN/A

VCNXN/A

Forward P/E (NTM)

HCWBN/A

VCNXN/A

Forward P/S (NTM)

HCWBN/A

VCNXN/A

Revenue (TTM)

HCWB$7M

VCNX$601K

Revenue Growth (YoY)

HCWB707.0%

VCNX5.4%

Forward Rev Growth

HCWB5564.5%

VCNX0.0%

Gross Margin (TTM)

HCWB95.9%

VCNX99.7%

Operating Margin (TTM)

HCWB23.1%

VCNX0.0%

EBITDA Margin (TTM)

HCWB-82.2%

VCNX-3101.7%

Net Margin (TTM)

HCWB-318.5%

VCNX-3100.5%

FCF Margin (TTM)

HCWB-180.6%

VCNX-2696.8%

Net Income (TTM)

HCWB$-21M

VCNX$-19M

FCF (TTM)

HCWB$-12M

VCNX$-16M

EPS (TTM)

HCWB-$16.12

VCNX-$5.78

ROE (TTM)

HCWB-1932.0%

VCNX-14678.0%

ROA (TTM)

HCWB-2145.0%

VCNX-43375.0%

ROIC (TTM)

HCWB-859.0%

VCNX-14238.0%

Cash

HCWB$741K

VCNX$1M

Debt

HCWB$7M

VCNX$25K

Net Cash/Debt

HCWB$-6M

VCNX$1M

Current Ratio (TTM)

HCWB0.06x

VCNX0.50x

Quick Ratio (TTM)

HCWB0.05x

VCNX0.38x

Debt/Equity (TTM)

HCWB0.88x

VCNX0.03x

Debt/Assets (TTM)

HCWB0.0%

VCNX0.0%

Interest Coverage (TTM)

HCWBN/A

VCNXN/A

Net Debt/EBITDA (TTM)

HCWB0.00x

VCNX0.00x

Beta

HCWB2.28

VCNX0.73

52W Performance

HCWB-94.5%

VCNX29.8%

YTD Performance

HCWB-76.2%

VCNX0.9%

% from 52W High

HCWB-94.3%

VCNX-24.0%

% from 52W Low

HCWB6.7%

VCNX267.7%

Asset Turnover (TTM)

HCWB0.26x

VCNX0.14x

FCF Yield (TTM)

HCWB-474.1%

VCNX-530.5%

Earnings Yield (TTM)

HCWB-836.3%

VCNX-609.9%

Dividend Yield (TTM)

HCWBN/A

VCNXN/A

Rule of 40

HCWB526.4

VCNX-2,691.4

EV/GP/RG

HCWB0.00

VCNXN/A

Ticker research

View HCWB research View VCNX research

Metric	HCWB HCW Biologics Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$8M	$2M
Price	$1.60	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	5.08x
EV/Sales	1.25x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$601K
Revenue Growth (YoY)	707.0%	5.4%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	99.7%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-3101.7%
Net Margin (TTM)	-318.5%	-3100.5%
FCF Margin (TTM)	-180.6%	-2696.8%
Net Income (TTM)	$-21M	$-19M
FCF (TTM)	$-12M	$-16M
EPS (TTM)	-$16.12	-$5.78
ROE (TTM)	-1932.0%	-14678.0%
ROA (TTM)	-2145.0%	-43375.0%
ROIC (TTM)	-859.0%	-14238.0%
Financial Health
Cash	$741K	$1M
Debt	$7M	$25K
Net Cash/Debt	$-6M	$1M
Current Ratio (TTM)	0.06x	0.50x
Quick Ratio (TTM)	0.05x	0.38x
Debt/Equity (TTM)	0.88x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.73
52W Performance	-94.5%	29.8%
YTD Performance	-76.2%	0.9%
% from 52W High	-94.3%	-24.0%
% from 52W Low	6.7%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.14x
FCF Yield (TTM)	-474.1%	-530.5%
Earnings Yield (TTM)	-836.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-2,691.4
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View VCNX research

Valuation

P/S Ratio

HCWB

0.38x

VCNX

5.08x

EV/FCF

HCWB

-0.69x

VCNX

-0.12x

Growth & revenue

Revenue Growth TTM

HCWB

707.0%

VCNX

5.4%

Forward Revenue Growth

HCWB

5564.5%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

HCWB

95.9%

ROE

HCWB

-1932.0%

VCNX

-14678.0%

FCF Yield %

HCWB

-474.1%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

HCWB

-94.5%

Detailed metrics comparison

HCWB

HCW Biologics Inc

VCNX

Vaccinex Inc

Market Cap

HCWB$3M

VCNX$3M

Enterprise Value

HCWB$8M

VCNX$2M

Price

HCWB$1.60

VCNX$1.14

P/E Ratio

HCWBN/A

VCNXN/A

P/S Ratio

HCWB0.38x

VCNX5.08x

EV/Sales

HCWB1.25x

VCNX3.28x

EV/EBITDA

HCWB0.00x

VCNX0.00x

P/B Ratio

HCWB0.51x

VCNX1.15x

P/FCF Ratio

HCWBN/A

VCNXN/A

EV/FCF

HCWB-0.69x

VCNX-0.12x

PEG Ratio

HCWBN/A

VCNXN/A

Forward P/E (NTM)

HCWBN/A

VCNXN/A

Forward P/S (NTM)

HCWBN/A

VCNXN/A

Revenue (TTM)

HCWB$7M

VCNX$601K

Revenue Growth (YoY)

HCWB707.0%

VCNX5.4%

Forward Rev Growth

HCWB5564.5%

VCNX0.0%

Gross Margin (TTM)

HCWB95.9%

VCNX99.7%

Operating Margin (TTM)

HCWB23.1%

VCNX0.0%

EBITDA Margin (TTM)

HCWB-82.2%

VCNX-3101.7%

Net Margin (TTM)

HCWB-318.5%

VCNX-3100.5%

FCF Margin (TTM)

HCWB-180.6%

VCNX-2696.8%

Net Income (TTM)

HCWB$-21M

VCNX$-19M

FCF (TTM)

HCWB$-12M

VCNX$-16M

EPS (TTM)

HCWB-$16.12

VCNX-$5.78

ROE (TTM)

HCWB-1932.0%

VCNX-14678.0%

ROA (TTM)

HCWB-2145.0%

VCNX-43375.0%

ROIC (TTM)

HCWB-859.0%

VCNX-14238.0%

Cash

HCWB$741K

VCNX$1M

Debt

HCWB$7M

VCNX$25K

Net Cash/Debt

HCWB$-6M

VCNX$1M

Current Ratio (TTM)

HCWB0.06x

VCNX0.50x

Quick Ratio (TTM)

HCWB0.05x

VCNX0.38x

Debt/Equity (TTM)

HCWB0.88x

VCNX0.03x

Debt/Assets (TTM)

HCWB0.0%

VCNX0.0%

Interest Coverage (TTM)

HCWBN/A

VCNXN/A

Net Debt/EBITDA (TTM)

HCWB0.00x

VCNX0.00x

Beta

HCWB2.28

VCNX0.73

52W Performance

HCWB-94.5%

VCNX29.8%

YTD Performance

HCWB-76.2%

VCNX0.9%

% from 52W High

HCWB-94.3%

VCNX-24.0%

% from 52W Low

HCWB6.7%

VCNX267.7%

Asset Turnover (TTM)

HCWB0.26x

VCNX0.14x

FCF Yield (TTM)

HCWB-474.1%

VCNX-530.5%

Earnings Yield (TTM)

HCWB-836.3%

VCNX-609.9%

Dividend Yield (TTM)

HCWBN/A

VCNXN/A

Rule of 40

HCWB526.4

VCNX-2,691.4

EV/GP/RG

HCWB0.00

VCNXN/A

Ticker research

View HCWB research View VCNX research

Metric	HCWB HCW Biologics Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$8M	$2M
Price	$1.60	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	5.08x
EV/Sales	1.25x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$601K
Revenue Growth (YoY)	707.0%	5.4%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	99.7%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-3101.7%
Net Margin (TTM)	-318.5%	-3100.5%
FCF Margin (TTM)	-180.6%	-2696.8%
Net Income (TTM)	$-21M	$-19M
FCF (TTM)	$-12M	$-16M
EPS (TTM)	-$16.12	-$5.78
ROE (TTM)	-1932.0%	-14678.0%
ROA (TTM)	-2145.0%	-43375.0%
ROIC (TTM)	-859.0%	-14238.0%
Financial Health
Cash	$741K	$1M
Debt	$7M	$25K
Net Cash/Debt	$-6M	$1M
Current Ratio (TTM)	0.06x	0.50x
Quick Ratio (TTM)	0.05x	0.38x
Debt/Equity (TTM)	0.88x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.73
52W Performance	-94.5%	29.8%
YTD Performance	-76.2%	0.9%
% from 52W High	-94.3%	-24.0%
% from 52W Low	6.7%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.14x
FCF Yield (TTM)	-474.1%	-530.5%
Earnings Yield (TTM)	-836.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-2,691.4
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View VCNX research